Signalling pathways in cardiac myocyte hypertrophy

Annals of Medicine

Volumn 33, Issue 9, 2001, Pages 611-622

  Sugden, Peter H ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

c Jun N terminal kinase; Calcineurin; Cardiac myocyte; Extracellular signal regulated kinase; Gene transcription; Hypertrophy; Intracellular Ca2+ concentration; Mitogen activated protein kinase; p38 mitogen activated protein kinase

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCINEURIN; CALCIUM ION; ENDOTHELIN 1; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN KINASE C; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR; VASOACTIVE AGENT;

CELL CULTURE; CELL DIVISION; CELL GROWTH; CELL ISOLATION; DEPHOSPHORYLATION; ENZYME ACTIVATION; ENZYME REGULATION; GENETIC TRANSCRIPTION; HEART CONTRACTION; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CALCINEURIN; GENE EXPRESSION REGULATION; HUMANS; HYPERTROPHY; MITOGEN-ACTIVATED PROTEIN KINASES; MYOCARDIUM; OXIDATIVE STRESS; PHOSPHORYLATION; PROTEIN KINASE C; SIGNAL TRANSDUCTION; TACROLIMUS;

EID: 0035683064     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (136)

1. Regulation of cardiac gene expression during myocardial growth and hypertrophy: Molecular studies of an adaptive physiologic response
2. Remodeling of ventricular myocytes during cardiac hypertrophy and heart failure
3. Cardiotrophin-1 activates a distinct form of cardiac hypertrophy. Assembly of sarcomeric units in series via gp130/leukemia inhibitory factor receptor-dependent pathways
4. Activated MEK5 induces serial assembly of sarcomeres and eccentric cardiac hypertrophy
5. Regulation of cardiomyocyte mechanotransduction by the cardiac cycle
6. Differentiation of rat myocytes in single cell cultures with and without proliferating nonmyocardial cells: Cross-striations, ultrastructure, and chronotropic response to isoproterenol
7. Myocyte hypertrophy in neonatal rat heart cell cultures and its regulation by serum and by catecholamines
8. 1 adrenergic response
9. 1-Adrenergic stimulation of cardiac gene transcription in neonatal rat myocardial cells. Effects on myosin light chain-2 gene expression
10. 1-mediated response
11. Co-regulation of the atrial natriuretic factor and cardiac myosin light chain-2 genes during alpha-adrenergic stimulation of neonatal rat ventricular cells. Identification of cis sequences within an embryonic and a constitutive contractile protein gene which mediate inducible expression
12. 1A-adrenergic receptor subtype mediates biochemical, molecular, and morphological features of cultured myocardial cell hypertrophy
13. Endothelin induction of inositol phospholipid hydrolysis, sarcomere assembly, and cardiac gene expression in ventricular myocytes. A paracrine mechanism for myocardial cell hypertrophy
14. Cellular mechanisms of cardiac hypertrophy
15. From sarcomere to nucleus: Role of genetics and signaling in structural heart disease
16. Calcineurin signaling and muscle remodeling
17. Cytoplasmic signaling pathways that regulate cardiac hypertrophy
18. Alpha-1 adrenergic stimulation of 1,4,5-inositol trisphosphate formation in ventricular myocytes
19. Endothelin inhibits adenyl cyclase and stimulates phosphoinositide hydrolysis in adult cardiac myocytes
20. Regulation of phospholipases C and D in rat ventricular myocytes. Stimulation by endothelin-1, bradykinin and phenylephrine
21. Regulation of phosphoinositide phospholipases by hormones, neurotransmitters, and other agonists linked to G proteins
22. G protein-coupled receptors and signaling pathways regulating growth responses
23. Cell signalling through guanine-nucleotide-binding regulatory proteins (G proteins) and phospholipases
24. Stress pathways and heart failure
25. A protein kinase C cDNA without the regulatory domain is active after transfection in vivo in the absence of phorbol ester
26. Expression of a constitutively activated mutant of the beta-isozyme of protein kinase C in cardiac myocytes stimulates the promoter of the betamyosin heavy chain isogene
27. Transcriptional activation of the cardiac myosin light chain 2 and atrial natriuretic factor genes by protein kinase C in neonatal rat ventricular myocytes
28. Phorbol esters induce immediate-early genes and activate cardiac gene transcription in neonatal rat myocardial cells
29. Classical, novel and atypical isoforms of PKC stimulate ANF- and TRE/AP-1-regulated-promoter activity in ventricular cardiomyocytes
30. Differential regulation of protein kinase C isoforms in isolated neonatal and adult rat cardiomyocytes
31. Differential activation of protein kinase C isoforms by endothelin-1 and phenylephrine, and subsequent stimulation of p42 and p44 mitogen-activated protein kinases in ventricular myocytes cultured from neonatal rat hearts
32. Transgenic overexpression of constitutively active protein kinase C epsilon causes concentric cardiac hypertrophy
33. Expression of protein kinase C beta in the heart causes hypertrophy in adult mice and sudden death in neonates
34. Targeted overexpression of protein kinase C beta2 isoform in myocardium causes cardiomyopathy
35. The search for physiological substrates of MAP and SAP kinases in mammalian cells
36. Endothelin-1, phorbol esters and phenylephrine stimulate MAP kinase activities in ventricular cardiomyocytes
37. Endothelin-1 and fibroblast growth factors stimulate the mitogen-activated protein kinase signaling cascade in cardiac myocytes. The potential role of the cascade in the integration of two signaling pathways leading to myocyte hypertrophy
38. Regulation of Ras.GTP loading and Ras-Raf association in neonatal rat ventricular myocytes by G protein-coupled receptor agonists and phorbol esters. Activation of the ERK cascade by phorbol esters is mediated by Ras
39. Expression of protein kinase C isoforms during cardiac ventricular development
40. Activated protein kinase C isoforms target to cardiomyocyte caveolae: Stimulation of local protein phosphorylation
41. Mitogen-activated protein kinases mediate changes in gene expression, but not cytoskeletal organization associated with cardiac muscle hypertrophy
42. Raf-1 kinase activity is necessary and sufficient for gene expression changes but not sufficient for cellular morphology changes associated with cardiac myocyte hypertrophy
43. The mitogen-activated protein kinase kinase MEK1 stimulates a pattern of gene expression typical of the hypertrophic phenotype in rat ventricular cardiomyocytes
44. Depletion of mitogen-activated protein kinase using an antisense oligodeoxynucleotide approach down-regulates the phenylephrine-induced hypertrophic response in rat cardiac myocytes
45. Stimulation of the p38 mitogen-activated protein kinase pathway in neonatal rat ventricular myocytes by the G protein-coupled receptor agonists endothelin-1 and phenylephrine: A role in cardiac myocyte hypertrophy?
46. Extracellular signal-regulated kinase (ERK) plays an essential role in hypertrophic agonists, endothelin-1 and phenylephrine-induced cardiomyocyte hypertrophy
47. Dissociation of p42 and p44 mitogen-activated protein kinase activation from receptor-induced hypertrophy in neonatal rat ventricular myocytes
48. HRas-dependent pathways can activate morphological and genetic markers of cardiac muscle cell hypertrophy
49. Oncogenic raf, src, and ras stimulate a hypertrophic pattern of gene expression and increase cell size in neonatal rat ventricular myocytes
50. The Raf-MEK-ERK cascade represents a common pathway for the alteration of intracellular calcium by Ras and protein kinase C in cardiac myocytes
51. The MEK1-ERK1/2 signaling pathway promotes compensated hypertrophy in transgenic mice
52. Inhibition of extracellular signal-regulated kinase enhances ischaemia/reoxygenation-induced apoptosis in cultured cardiac myocytes and exaggerates reperfusion injury in isolated perfused heart
53. Increasing complexity of the Ras signaling pathway
54. Small GTP-binding proteins
55. Cell signaling by receptor tyrosine kinases
56. Ras recruits Raf-1 to the plasma membrane for activation by tyrosine phosphorylation
57. Serine and tyrosine phosphorylations cooperate in raf-1, but not B-Raf activation
58. Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane
59. Eyes wide shut: Protein kinase C isozymes are not the only receptors for the phorbol ester tumor promoters
60. Activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by conventional, novel, and atypical protein kinase C isotypes
61. Protein kinase C activates RAF-1 by direct phosphorylation
62. Constitutive association of c-N-Ras with c-Raf-1 and protein kinase Cepsilon in latent signaling modules
63. Hypertrophic agonists stimulate the activities of the protein kinases c-Raf and A-Raf in cultured ventricular myocytes
64. Signal transduction by the JNK group of MAP kinases
65. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation
66. Regulation of MEF2 by p38-MAPK and its implication for cardiomyocyte biology
67. Cellular stresses activate c-Jun N-terminal protein kinases (JNKs) in ventricular myocytes cultured from neonatal rat hearts
68. Activation of mitogen-activated protein kinases (p38-MAPKs, SAPKs/JNKs and ERKs) by the G protein-coupled receptor agonist phenylephrine in the perfused rat heart
69. Stimulation of the stress-activated mitogen-activated protein kinases subfamilies in perfused heart, p38/RK (HOG-1-related) kinases and c-Jun N-terminal kinases (JNK/SAPKs) are activated by ischemia-reperfusion
70. Stimulation of "stress-regulated" mitogen-activated protein kinases (SAPKs/JNKs and p38-MAPKs) in perfused rat hearts by oxidative and other stresses
71. 1-adrenergic receptor and fas activation and is associated with in vitro and in vivo cardiac hypertrophy
72. A role for the p38 mitogen-activated protein kinase pathway in myocardial cell growth, sarcomeric organization, and cardiac-specific gene expression
73. Opposing effects of Jun kinase and p38 mitogen-activated protein kinases on cardiomyocyte hypertrophy
74. p38-Mitogen-activated protein kinase mediates the transcriptional induction of the atrial natriuretic factor gene through a serum response element. A potential role for the transcription factor ATF6
75. Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family
76. 2-terminal kinase in ventricular muscle cells
77. TAK1 is activated in the myocardium after pressure overload and is sufficient to provoke heart failure in transgenic mice
78. Activation of c-Jun N-terminal kinases and p38-mitogen-activated protein kinases in human heart failure secondary to ischemic heart disease
79. Decrease p38 MAPK activity in end-stage failing human myocardium: p38 MAPKalpha is the predominant isoform expressed in human heart
80. Differential activation of signal transduction pathways in human hearts with hypertrophy versus advanced heart failure
81. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis
82. Requirement of JNK for stress-induced activation of the cytochrome c-mediated cell death pathway
83. Possible involvement of stress-activated protein kinase signaling pathway and Fas receptor expression in prevention of ischemia-reperfusion-induced cardiomyocyte apoptosis by carvedilol
84. Carvedilol inhibits activation of stress-activated protein kinase and reduces reperfusion injury in perfused rabbit hearts
85. Activation of the JNK pathway is important for cardiomyocyte death in response to simulated ischemia
86. Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion
87. Inhibition of p38 MAPKalpha/beta reduces ischemic injury and does not block protective effects of preconditioning
88. Apoptosis in cardiac disease states: Stress- and mitogen-activated signaling pathways
89. An inhibitor of p38 mitogen-activated protein kinase protects neonatal cardiac myocyte from ischemia
90. The role of differential activation of p38-mitogen-activated protein kinase in preconditioned myocytes
91. Cytoprotection by Jun kinase during nitric oxide-induced cardiac myocyte apoptosis
92. SAPKs regulation of preconditioning
93. Role of phasic dynamism of p38 mitogen-activated protein kinase activation in ischemic preconditioning of the canine heart
94. Mitogen-activated protein kinases mediate heat shock-induced delayed protection in mouse heart
95. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy
96. Regulation of the calmodulin-stimulated protein phosphatase, calcineurin
97. Calcineurin: Form and function
98. A rho gene product in human blood platelets. I. Identification of the platelet substrate for botulinum C3 ADP-ribosyltransferase as rhoA protein
99. Calcineurin and beyond, cardiac hypertrophic signaling
100. Prevention of cardiac hypertrophy in mice by calcineurin inhibition
101. Cyclosporine attenuates pressure-overload hypertrophy in mice while enhancing susceptibility to decompensation and failure
102. Calcineurin plays a critical role in pressure overload-induced cardiac hypertrophy
103. Calcineurin blockade prevents cardiac mitogen-activated protein kinase activation and hypertrophy in renovascular hypertension
104. Calcineurin inhibitor attenuates left ventricular hypertrophy, leading to prevention of heart failure in hypertensive rats
105. Calcineurin inhibition and cardiac hypertrophy
106. Pressure overload induces severe hypertrophy in mice treated with cyclosporine, an inhibitor of calcineurin
107. Targeted inhibition of calcineurin attenuates cardiac hypertrophy in vivo
108. Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo
109. 2+ response amplitude and duration
110. Calcium oscillations increase the efficiency and specificity of gene transcription
111. 2-terminal kinase activation in the heart. Cross-talk between cardiac hypertrophic signaling pathways
112. 2+-induced apoptosis through calcineurin dephosphorylation of BAD
113. Calcineurin is downstream of the inositol 1,4,5-trisphosphate receptor in the apoptotic and cell growth pathways
114. Calcineurin-mediated hypertrophy protects cardiomyocytes from apoptosis in vitro and in vivo: An apoptosis-independent model of dilated heart failure
115. Beta-adrenergic pathway induces apoptosis through calcineurin activation in cardiac myocytes
116. Calcineurin pathway is required for endothelin-1-mediated protection against oxidative stress in cardiac myocytes
117. The mitochondrial permeability transition pore and its role in cell death
118. Mitochondria and apoptosis
119. Mitochondrial control of cell death
120. + currents in rat ventricular myocytes
121. Intracellular calcium-release channels: Regulators of cell life and death
122. p21ras and calcineurin synergize to regulate the nuclear factor of activated T cells
123. Calcium, calcineurin, and the control of transcription
124. 2+-calmodulin and protein kinase Cs: A hypothetical synthesis of the conflicting convergences on shared substrate domains
125. 2+ transients, and contractility in rabbit ventricular myocardium
126. Cardiac protein phosphorylation: Functional and pathophysiological correlates
127. Regulation of cardiac L-type calcium channels by protein kinase A and protein kinase C
128. 2+ in isolated mammalian ventricular myocytes
129. Phosphorylation of the calcium-dependent protein phosphatase by protein kinase C
130. 2+/calmodulin-dependent protein kinase II and protein kinase C
131. Ras regulates NFAT3 activity in cardiac myocytes
132. i regulation and cell morphology
133. Alterations in calcium handling in cardiac hypertrophy and heart failure
134. 2+ currents in compensated hypertrophy and heart failure
135. The role of action potential elongation and altered intracellular calcium handling in the pathogenesis of heart failure
136. Multiple, distinct forms of bovine and human protein kinase C suggest diversity in cellular signaling pathways